Literature DB >> 26235023

Spinal ependymomas. Part 1: Intramedullary ependymomas.

Jörg Klekamp1.   

Abstract

OBJECT Ependymomas represent the most common intramedullary tumor in adults. Despite their usually well-defined dissection plane, surgical morbidity has been documented to be considerably higher compared with other intramedullary entities. This study presents an analysis of risk factors for surgical morbidity and data on long-term results for intramedullary ependymomas. METHODS Among 1447 patients with tumors of the spinal canal treated between 1980 and 2014, 309 patients presented with intramedullary tumors. One hundred patients with intramedullary ependymomas underwent 102 operations. Mean age was 44 ± 15 years (range 8-74 years). Patients were followed by outpatient visits and questionnaires, with a mean follow-up of 77 ± 91 months. Short-term results were determined for individual symptoms and the McCormick Scale, whereas tumor recurrence rates were calculated with Kaplan-Meier statistics. RESULTS Compared with cervical ependymomas, those of the thoracic spine were associated with more severe motor deficits and gait problems at presentation. A total of 86.3% of patients with intramedullary ependymomas underwent gross-total resection (GTR). A low preoperative McCormick grade and first surgery were the strongest predictors for a GTR. Postoperatively, 67.6% of patients demonstrated a worse neurological state at discharge from the hospital. This deterioration was transient for 40.1% of the patients and permanent for 27.5%. In the long term, the McCormick grade remained unchanged from the preoperative grade in 74.5% of patients, while it was improved in 5.9% of patients and increased after surgery in 19.6% of patients. According to a multivariate analysis, the risk of permanent morbidity increased with a thoracic level of the ependymoma, advanced age, a long clinical history, presence of a tumor hemorrhage, and surgery on a recurrent tumor. In the long term, tumor recurrence rates correlated significantly with the amount of resection (4.2% and 18.5% in 20 years after GTR and partial resections, respectively). Postoperative neuropathic pain syndromes affected 37.0% of patients, whereas 4% demonstrated a postoperative myelopathy related to cord tethering at the level of surgery. CONCLUSIONS Intramedullary ependymomas are tumors best treated surgically. A complete resection indicates cure for the overwhelming majority of these patients. Surgery should be performed early by neurosurgeons who deal with these lesions on a regular basis to achieve high GTR rates. Permanent surgical morbidity varies most according to tumor location and patient age.

Entities:  

Keywords:  GTR = gross-total resection; NF2 = neurofibromatosis Type 2; intramedullary tumors; neuropathic pain; syringomyelia

Mesh:

Year:  2015        PMID: 26235023     DOI: 10.3171/2015.5.FOCUS15161

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  18 in total

1.  Natural history of intramedullary spinal cord ependymoma in patients preferring nonoperative treatment.

Authors:  Bedjan Behmanesh; Florian Gessler; Stephan Dützmann; Daniel Dubinski; Lioba Imoehl; Volker Seifert; Matthias Setzer; Gerhard Marquardt
Journal:  J Neurooncol       Date:  2017-06-30       Impact factor: 4.130

Review 2.  Spinal cord ependymoma: a review of the literature and case series of ten patients.

Authors:  Emma Celano; Arsalaan Salehani; James G Malcolm; Erik Reinertsen; Constantinos G Hadjipanayis
Journal:  J Neurooncol       Date:  2016-05-06       Impact factor: 4.130

3.  Clinical Prediction Modeling in Intramedullary Spinal Tumor Surgery.

Authors:  Elie Massaad; Yoon Ha; Ganesh M Shankar; John H Shin
Journal:  Acta Neurochir Suppl       Date:  2022

4.  Treatment strategy for multisegmental cervicomedullary ependymoma: illustrative case.

Authors:  Andrei A Zrelov; Malik M Tastanbekov; Mikhail V Alexandrov; Anastasiia S Nechaeva; Olga A Toporkova; Olga M Vorobeva; Konstantin A Samochernykh
Journal:  J Neurosurg Case Lessons       Date:  2021-12-20

5.  Clinical characteristics and surgical outcomes of ependymomas in the upper cervical spinal cord: a single-center experience of 155 consecutive patients.

Authors:  Xiaobin Fei; Wenqing Jia; Heng Gao; Chenlong Yang; Da Li; Zenghui Qian; Bo Han; Dejiang Wang; Yulun Xu
Journal:  Neurosurg Rev       Date:  2020-08-07       Impact factor: 3.042

6.  Preoperative steroids do not improve outcomes for intramedullary spinal tumors: a NSQIP analysis of 30-day reoperation and readmission rates.

Authors:  Abhiraj D Bhimani; Morteza Sadeh; Darian R Esfahani; Gregory D Arnone; Steven Denyer; Jack Zakrzewski; Pouyan Kheirkhah; Tania M Aguilar; Kate Louise D Milan; Ankit I Mehta
Journal:  J Spine Surg       Date:  2018-03

7.  Magnetic Drug Targeting: A Novel Treatment for Intramedullary Spinal Cord Tumors.

Authors:  Pouyan Kheirkhah; Steven Denyer; Abhiraj D Bhimani; Gregory D Arnone; Darian R Esfahani; Tania Aguilar; Jack Zakrzewski; Indu Venugopal; Nazia Habib; Gary L Gallia; Andreas Linninger; Fady T Charbel; Ankit I Mehta
Journal:  Sci Rep       Date:  2018-07-30       Impact factor: 4.379

8.  Spinal myxopapillary ependymoma in an adult male presenting with recurrent acute low back pain: a case report.

Authors:  Dean Petersen; Reidar P Lystad
Journal:  Chiropr Man Therap       Date:  2016-04-18

9.  Acute Paraplegia as a Result of Hemorrhagic Spinal Ependymoma Masked by Spinal Anesthesia: Case Report and Review of Literature.

Authors:  Sang-Hyo Lee; David Jaehyun Park; Sin-Soo Jeun
Journal:  Brain Tumor Res Treat       Date:  2016-04-29

10.  Fluorescence Guided Surgery with 5-Aminolevulinic Acid for Resection of Spinal Cord Ependymomas.

Authors:  Rafael García Moreno; Luis Miguel Bernal García; Hyaissa Ippolito Bastidas; Carlos Andrés Mondragón Tirado; Aurora Moreno Flores; Juan Pablo Sosa Cabezas; José Manuel Cabezudo Artero
Journal:  Asian Spine J       Date:  2018-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.